Purification platform for bispecific antibodies
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsAndrew Tustian, Christine Endicott, Benjamin Adams, John Mattila, Hanne Bak
Life of this patent
Estimating the term…
Loading patent…
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsAndrew Tustian, Christine Endicott, Benjamin Adams, John Mattila, Hanne Bak
Estimating the term…
High resolution protein A chromatography employing a chaotropic agent and pH gradient or pH step elution buffer results in improved peak resolution between closely related molecular species. Bispecific antibodies containing a protein A-binding-ablating substitution CH3 domain paired with a protein A-binding CH3 domain are separated with high peak resolution from monospecific antibodies containing a protein A-binding-ablating substituted CH3 domain paired with the protein A-binding-ablating substituted CH3 domain and monospecific antibodies containing a protein A-binding CH3 domain paired with the protein A-binding CH3 domain. Useful chaotropic agents include magnesium chloride and calcium chloride.
A method of making a protein comprising:
A method of producing a protein comprising the steps of:
Dependencies are inferred from the claim text.